Financial Support

Image by Aaron Burden

Teal in Need

In Honor of the Cathy Mislinski Legacy Gift

WOCA’s “Teal In Need” campaign focuses on financially assisting ovarian cancer patient’s Physician Fees or Hospital Expenses, while they are currently undergoing treatment or have finished treatment within the past 6 months. WOCA defines “treatment” as: chemotherapy, radiation, surgery, clinical trials, and/or therapy/program regimen.


WOCA assists individuals regardless of their race, age, religion, or sexual orientation. To be eligible for financial assistance, you must be an ovarian cancer patient living or receiving treatment in Wisconsin, unless otherwise approved by the “Teal In Need” committee.

Applications accepted quarterly.

leaf background for CRLF.jpg

The Connie Rutledge Legacy Fund (CRLF)

The Connie Rutledge Legacy Fund (CRLF) was founded to assist those impacted by ovarian and other gynecological cancers as well as ovarian cancer research. CRLF assists individuals regardless of age, gender, race, religion or sexual orientation.

To be eligible for financial assistance you must be undergoing treatment for ovarian or other gynecological cancer. All recipients need to be a resident of Wisconsin.  Applicant’s income restriction is 250% or less of federal poverty levels and/or whose insurance/Medicare assistance is not sufficient for applicant to maintain financial stability.

Other Financial Assistance

The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Partnering with generous donors, healthcare providers and pharmacies, PAN provides the under-insured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. Since its founding in 2004, PAN has provided nearly 1 million under-insured patients with over $2.6 billion in financial assistance, through nearly 60 disease-specific programs.